<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="365278">
  <stage>Registered</stage>
  <submitdate>10/11/2013</submitdate>
  <approvaldate>14/11/2013</approvaldate>
  <actrnumber>ACTRN12613001252707</actrnumber>
  <trial_identification>
    <studytitle>Determination Of Optimum Time For Intravenous Cannulation after Induction with Sevoflurane, Nitrous Oxide mixture in children undergoing  Midazolam   Sedation</studytitle>
    <scientifictitle>Optimum time for intravenous cannulation after inhalational induction of sevoflurane and nitrous oxide general anaesthesia after midazolam premedication in children undergoing elective surgery</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Aim of this study to determine the optimal time of intravenous
cannulation in children induced with sevoflurane.</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Anaesthetics</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Children  will premedicated with oral midazolam (0.5 mg/kg)  mixed in a small amount of strawberry syrup (total volume of 5 ml).
General anesthesia was induced with sevoflurane and nitrous oxide  via face mask .For the first child,  four minutes after the loss of eyelash reflex,  the intravenous cannulation was attempted by an experienced anesthetist. At the time of intravenous canulation attempt,  an independent observer who was blinded about predetermined canulation time, rated the movement according to a scale (0= no movement 1= slight extremity tensing, 2= extremity withdrawal, 3=generalized movement). Intravenous
cannulation without any laryngospasm or movement  was considered successful.The intravenous cannulation time  of the next patient was determined by the use of up-and-down method (15 s as a step size).The observation  was
concluded after intravenous cannulation and the case
proceeded as per routine. The sample size of the patients  is based on Dixons up-and-down method that requires at least six
pairs of failure success.
</interventions>
    <comparator>N/A - This is an observational study</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Not applicable</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Determination of optimum time for intravenous cannulation after induction with Sevoflurane, Nitrous Oxide mixture in children undergoing Midazolam Sedation

At the time of intravenous canulation attempt, an independent observer who was blinded about predetermined canülation time, rated the movement according to a scale (0= no movement 1= slight extremity tensing, 2= extremity withdrawal, 3=generalized movement
Intravenous cannulation without any laryngospasm or movement was considered successful.
At the time of intravenous canulation attempt, an independent observer who was blinded about predetermined canülation time, rated the movement according to a scale (0= no movement 1= slight extremity tensing, 2= extremity withdrawal, 3=generalized movement
Intravenous cannulation without any laryngospasm or movement was considered successful.</outcome>
      <timepoint>For the first child,  four minutes after the loss of eyelash reflex,  the intravenous cannulation was attempted by an experienced anesthetist.The intravenous cannulation time  of the next patient was determined by the use of up-and-down method (15 s as a step size). Assessed and  concluded immediately after  iv cannulation.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>To assess Bispectral Index BIS changes  during induction of anaesthesia with sevoflurane in children premedicated with midazolam </outcome>
      <timepoint>BIS values at preinduction, loss of eyelash reflex,  before and after (10 s) cannulation attempt and when the pupils return to the mid position will  recorded.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Participant are children with ASA physical status I and scheduled for an elective procedure under general anesthesia without prior intravenous cannulation were selected.</inclusivecriteria>
    <inclusiveminage>2</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>6</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>history of an upper respiratory tract infection,abnormal airway, reactive airway disease,</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods>The sample size calculation is on Dixon's method that needs at least six pairs of failure-success .

Probit test will used for analysis of up-and-down sequences to obtain the time for intravenous cannulation and calculating 95% confidence limits (CL) of the mean. </statisticalmethods>
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs>Psychosocial</purposeobs>
    <duration>Longitudinal</duration>
    <selection>Defined population</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Phase 0</phase>
    <anticipatedstartdate />
    <actualstartdate>1/06/2013</actualstartdate>
    <anticipatedenddate>14/11/2013</anticipatedenddate>
    <actualenddate>7/11/2013</actualenddate>
    <samplesize>32</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up continuing</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Turkey</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Necmettin Erbakan University  </primarysponsorname>
    <primarysponsoraddress>Necmettin Erbakan University

Department of Anesthesiology and Reanimation

Meram School of Medicine 42080

Meram, Konya, TURKEY </primarysponsoraddress>
    <primarysponsorcountry>Turkey</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>Necmettin Erbakan University

Department of Anesthesiology and Reanimation
</fundingname>
      <fundingaddress>Necmettin Erbakan University

Department of Anesthesiology and Reanimation

Meram School of Medicine 42080

Meram, Konya, TURKEY </fundingaddress>
      <fundingcountry>Turkey</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>It has been shown that early placement of an intravenous cannulation in children anesthetized with sevoflurane movement was greater, and the incidence of laryngospasm was higher. The aim of this study is determine the optimal time for safe intravenous cannulation in children induced with sevoflurane and nitrous oxide after midazolam premedication.
Children aged 2-6 years, ASA physical status I, will scheduled for an elective procedure under general anesthesia will recruited. Patients will received oral midazolam(0.5 mg) Inhalational anesthesia will induced with sevoflurane nitrous oxide via mask, then intravenous cannulation will attempted. The time for intravenous cannulation will determined by the use of up-and-down method using 15 s as a step size. Intravenous cannulation without any movement, or laryngospasm will considered successful. The up-and-down sequences will  analyzed by the probit test. The sample size calculation will based on Dixon's method that needs at least six pairs of failure-success
</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Necmettin Erbakan University  Department of Anesthesiology and Reanimation  Meram School of Medicine </ethicname>
      <ethicaddress>Necmettin Erbakan University

Department of Anesthesiology and Reanimation

Meram School of Medicine 42080

Meram, Konya, TURKEY </ethicaddress>
      <ethicapprovaldate>17/04/2012</ethicapprovaldate>
      <hrec>2012.42</hrec>
      <ethicsubmitdate>9/04/2012</ethicsubmitdate>
      <ethiccountry>Turkey</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>A/Prof</title>
      <name>Alper Kilicaslan</name>
      <address>Necmettin Erbakan University

Department of Anesthesiology and Reanimation

Meram School of Medicine 42080

Meram, Konya, TURKEY </address>
      <phone>+905053780376</phone>
      <fax />
      <email>dralperkilicaslan@gmail.com</email>
      <country>Turkey</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Seref Otelcioglu</name>
      <address>Necmettin Erbakan University

Department of Anesthesiology and Reanimation

Meram School of Medicine 42080

Meram, Konya, TURKEY </address>
      <phone>+903322236550</phone>
      <fax />
      <email>sotelcioglu@konya.edu.tr</email>
      <country>Turkey</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Seref Otelcioglu</name>
      <address>Necmettin Erbakan University

Department of Anesthesiology and Reanimation

Meram School of Medicine 42080

Meram, Konya,  </address>
      <phone>+903322236550</phone>
      <fax />
      <email>sotelcioglu@konya.edu.tr</email>
      <country>Turkey</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>